Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Nov;10(11):803-8.
doi: 10.1038/nrc2946. Epub 2010 Oct 14.

The Genesis and Evolution of High-Grade Serous Ovarian Cancer

Affiliations
Review

The Genesis and Evolution of High-Grade Serous Ovarian Cancer

David D L Bowtell. Nat Rev Cancer. .

Abstract

Germline mutation in either BRCA1 or BRCA2 is associated with an increased risk of ovarian cancer, particularly the most common invasive histotype - serous carcinoma. In addition, serous ovarian cancers have an unusually high frequency of other molecular events involving BRCA pathway dysfunction. Recent findings show a high frequency of TP53 mutation, chromosomal instability, distinct molecular subtypes and DNA copy number-driven changes in gene expression. These findings suggest a model in which homologous recombination repair deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy.

Comment in

  • The forgotten fallopian tube.
    Dietl J, Wischhusen J. Dietl J, et al. Nat Rev Cancer. 2011 Mar;11(3):227; author reply 227. doi: 10.1038/nrc2946-c1. Nat Rev Cancer. 2011. PMID: 21326326 No abstract available.

Similar articles

See all similar articles

Cited by 149 articles

See all "Cited by" articles

References

    1. Cancer Biol Ther. 2006 Mar;5(3):256-60 - PubMed
    1. Breast Cancer. 2008;15(2):153-8 - PubMed
    1. Nat Rev Cancer. 2006 Dec;6(12):924-35 - PubMed
    1. J Natl Cancer Inst. 2002 Jan 2;94(1):61-7 - PubMed
    1. Cancer Cell. 2005 Jul;8(1):35-47 - PubMed

LinkOut - more resources

Feedback